To include your compound in the COVID-19 Resource Center, submit it here.

Trius, Bayer in deal for torezolid

Trius Therapeutics Inc. (NASDAQ:TSRX) granted Bayer AG (Xetra:BAY) exclusive rights to antibiotic candidate torezolid in China, Japan, Africa, Latin

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE